Ashley A. Lowe

Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022

Ashley Fowlkes, Sarang K. Yoon, Karen Lutrick et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 182 citations · Full text

Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12–17 Years — Arizona, July–December 2021

Karen Lutrick, Patrick Rivers, Young M. Yoo et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 46 citations · Full text

Immunodeficiencies, Covid-19 Epidemiology, Vaccine Hesitancy +23

Managing respiratory emergencies at school: A county-wide stock inhaler program

Ashley A. Lowe, Joe K. Gerald, Conrad J. Clemens et al. · Journal of Allergy and Clinical Immunology · 2021 · 23 citations

Pulmonary Care, Patient Safety, Pediatrics +9

Ensuring Access to Albuterol in Schools: From Policy to Implementation. An Official ATS/AANMA/ALA/NASN Policy Statement

Anna Volerman, Ashley A. Lowe, Andrea A. Pappalardo et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 21 citations · Full text

Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers

Katherine Ellingson, James Hollister, Cynthia Porter et al. · Emerging infectious diseases · 2023 · 16 citations · Full text

Virus Epidemiology, Essential Workers, Vaccine Hesitancy +18